SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-17-003099
Filing Date
2017-03-31
Accepted
2017-03-31 06:45:46
Documents
64
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 2159556
2 ex31-1.htm EX-31.1 17140
3 ex31-2.htm EX-31.2 16260
4 ex32-1.htm EX-32.1 7447
5 ex32-2.htm EX-32.2 7742
6 image_001.jpg GRAPHIC 16981
  Complete submission text file 0001493152-17-003099.txt   5195960

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE imun-20161231.xml EX-101.INS 626383
8 XBRL SCHEMA FILE imun-20161231.xsd EX-101.SCH 54125
9 XBRL CALCULATION FILE imun-20161231_cal.xml EX-101.CAL 49859
10 XBRL DEFINITION FILE imun-20161231_def.xml EX-101.DEF 151133
11 XBRL LABEL FILE imun-20161231_lab.xml EX-101.LAB 323562
12 XBRL PRESENTATION FILE imun-20161231_pre.xml EX-101.PRE 236913
Mailing Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801
Business Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801 (888) 613-8802
Immune Therapeutics, Inc. (Filer) CIK: 0001559356 (see all company filings)

IRS No.: 593226705 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-54933 | Film No.: 17727933
SIC: 2834 Pharmaceutical Preparations